Search Results for agency_names:"Health and Human Services Department"

The National Institute of General Medical Sciences, part of the National Institutes of Health, announced two upcoming closed meetings on March 3 and March 25, 2021. These meetings are closed to the public because they will involve reviewing grant applications that could reveal confidential information. The March 3 meeting will focus on the National Institute of General Medical Sciences Special Emphasis Panel's review of PRAT Applications, while the March 25 meeting will review the Postdoctoral Research Associate Training (PRAT) Program. The meetings will take place online via video at the NIH campus in Bethesda, Maryland.

The Food and Drug Administration (FDA) has determined that NASCOBAL, a nasal spray containing 0.5 mg of cyanocobalamin (vitamin B12), was not removed from the market due to safety or effectiveness concerns. This decision means that the FDA will continue to approve generic versions of NASCOBAL as long as they meet all legal and regulatory requirements. The drug remains listed in the "Discontinued Drug Product List" section of the Orange Book, which indicates it was not discontinued for safety reasons. If needed, the FDA will instruct generic drug makers to update their labeling to current standards.

The Centers for Disease Control and Prevention (CDC) has submitted a request to extend an existing information collection project about Factors Influencing the Transmission of Influenza to the Office of Management and Budget (OMB). The study aims to better understand how the influenza virus spreads, especially through the air, by examining airborne particles and biomarkers in the blood of volunteers. The study was paused due to COVID-19 but is now seeking to continue for three more years, involving 270 volunteer participants in total. The CDC is asking for public comments on this project for 30 days, with a particular interest in whether the information collection is necessary, its accuracy, and how the burden of participating can be minimized.

The National Institute of Neurological Disorders and Stroke is holding a closed meeting on February 3-4, 2025, to review and evaluate grant applications related to neurological sciences and disorders. This meeting will be conducted virtually and is not open to the public to protect confidential trade secrets and personal information of those involved with the grant applications. For further details, individuals can contact Ana Olariu at the National Institutes of Health.

The National Heart, Lung, and Blood Advisory Council will hold a virtual meeting on February 4, 2025. The meeting is open to the public from 9:30 a.m. to 3:00 p.m., where program policies and issues will be discussed. It will start with a closed session from 9:00 a.m. to 9:30 a.m. dedicated to reviewing grant applications. The public can watch the meeting through the NIH Videocast website, and those interested in making oral comments to the committee should notify the contact person at least ten days before the meeting.

The National Institutes of Health is announcing a closed meeting for the National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel (NIDDK RC2 SEP). This meeting will take place virtually on April 11, 2025, from 1:00 p.m. to 2:30 p.m. and is closed to the public to protect sensitive information about grant applications. The meeting will review and evaluate these applications, and any open discussion could reveal confidential trade secrets or personal data. Dr. Xiaodu Guo is the contact person for further information regarding this meeting.

The National Advisory Dental and Craniofacial Research Council is having a meeting on April 18, 2025. The meeting will be closed to the public to protect confidential information, including trade secrets and personal details about individuals involved with grant applications. The agenda includes reviewing a report to the council and evaluating grant applications. The meeting will be held virtually, and further details and an agenda will be available on the National Institute of Dental & Craniofacial Research's website.

The Centers for Medicare & Medicaid Services (CMS), under the Department of Health and Human Services, has announced a funding opportunity to develop electronic clinical quality measures (eCQM) for radiology in hospital programs. The aim is to improve programs like the Hospital Inpatient and Outpatient Quality Reporting Programs by supporting the development and use of quality measures. CMS plans to award a contract to Alara Imaging, a company equipped with the necessary expertise and software for this project. This notice does not require any information collection from the public.

The National Institute of Diabetes and Digestive and Kidney Diseases is holding a closed meeting from March 10 to 12, 2021. This meeting is to review and evaluate grant applications and will not be open to the public due to the potential disclosure of confidential information, such as trade secrets and personal data. The meeting will take place via video at the National Institutes of Health in Bethesda, Maryland. For more information, contact Charlene J. Repique, Ph.D., the Scientific Review Officer.

The National Institute of Mental Health is holding a virtual meeting on April 29-30, 2025, which will be closed to the public. This is due to the potential discussion of confidential materials and personal information related to grant applications. The meeting will review these grant applications and is organized by Rebecca Steiner Garcia, Ph.D., the Scientific Review Officer at the National Institutes of Health. The meeting location will be the Neuroscience Center in Rockville, Maryland, but it will be conducted online.